1.Grandner MA. Sleep, Health, and Society. Sleep Med Clin. 2017;12(1):1–22.
2.Foster RG, Wulff K. The rhythm of rest and excess. Nature reviews Neuroscience. 2005;6(5):407–14.
3.Brouwer A, van Raalte DH, Diamant M, Rutters F, van Someren EJ, Snoek FJ, et al. Light therapy for better mood and insulin sensitivity in patients with major depression and type 2 diabetes: a randomised, double-blind, parallel-arm trial. BMC Psychiatry. 2015;15:169.
4.Baron KG, Reid KJ. Circadian misalignment and health. Int Rev Psychiatry. 2014;26(2):139–54.
5.Rumble ME, Dickson D, McCall WV, Krystal AD, Case D, Rosenquist PB, et al. The relationship of person-specific eveningness chronotype, greater seasonality, and less rhythmicity to suicidal behavior: A literature review. J Affect Disord. 2018;227:721–30.
6.Langsrud K, Kallestad H, Vaaler A, Almvik R, Palmstierna T, Morken G. Sleep at night and association to aggressive behaviour; Patients in a Psychiatric Intensive Care Unit. Psychiatry Res. 2018;263:275–9.
7.Langsrud K, Vaaler AE, Kallestad H, Morken G. Sleep patterns as a predictor for length of stay in a psychiatric intensive care unit. Psychiatry Res. 2016;237:252–6.
8.Wulff K, Gatti S, Wettstein JG, Foster RG. Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nature reviews Neuroscience. 2010;11(8):589–99.
9.Kallestad H, Hansen B, Langsrud K, Ruud T, Morken G, Stiles TC, et al. Impact of sleep disturbance on patients in treatment for mental disorders. BMC Psychiatry. 2012;12:179.
10.Goldstein AN, Walker MP. The role of sleep in emotional brain function. Annu Rev Clin Psychol. 2014;10:679–708.
11.Manber R, Edinger JD, Gress JL, San Pedro-Salcedo MG, Kuo TF, Kalista T. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep. 2008;31(4):489–95.
12.Harvey AG, Soehner AM, Kaplan KA, Hein K, Lee J, Kanady J, et al. Treating insomnia improves mood state, sleep, and functioning in bipolar disorder: a pilot randomized controlled trial. J Consult Clin Psychol. 2015;83(3):564–77.
13.Perlis ML, Grandner MA, Brown GK, Basner M, Chakravorty S, Morales KH, et al. Nocturnal Wakefulness as a Previously Unrecognized Risk Factor for Suicide. J Clin Psychiatry. 2016;77(6):e726–33.
14.Sheaves B, Freeman D, Isham L, McInerney J, Nickless A, Yu LM, et al. Stabilising sleep for patients admitted at acute crisis to a psychiatric hospital (OWLS): an assessor-blind pilot randomised controlled trial. Psychol Med. 2018;48(10):1694–704.
15.Creado S, Plante DT. An Update on the Use of Sedative-Hypnotic Medications in Psychiatric Disorders. Current psychiatry reports. 2016;18(9):78.
16.Jansson-Frojmark M, Norell-Clarke A. Cognitive Behavioural Therapy for Insomnia in Psychiatric Disorders. Curr Sleep Med Rep. 2016;2(4):233–40.
17.Roehrs T, Verster JC, Koshorek G, Withrow D, Roth T. How representative are insomnia clinical trials? Sleep Med. 2018;51:118–23.
18.Dallaspezia S, Suzuki M, Benedetti F. Chronobiological Therapy for Mood Disorders. Current psychiatry reports. 2015;17(12):95.
19.Wehr TA, Turner EH, Shimada JM, Lowe CH, Barker C, Leibenluft E. Treatment of rapidly cycling bipolar patient by using extended bed rest and darkness to stabilize the timing and duration of sleep. Biol Psychiatry. 1998;43(11):822–8.
20.Wirz-Justice A, Quinto C, Cajochen C, Werth E, Hock C. A rapid-cycling bipolar patient treated with long nights, bedrest, and light. Biol Psychiatry. 1999;45(8):1075–7.
21.Barbini B, Benedetti F, Colombo C, Dotoli D, Bernasconi A, Cigala-Fulgosi M, et al. Dark therapy for mania: a pilot study. Bipolar Disord. 2005;7(1):98–101.
22.Brainard GC, Hanifin JP, Greeson JM, Byrne B, Glickman G, Gerner E, et al. Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2001;21(16):6405–12.
23.Phelps J. Dark therapy for bipolar disorder using amber lenses for blue light blockade. Med Hypotheses. 2008;70(2):224–9.
24.Henriksen TE, Skrede S, Fasmer OB, Hamre B, Gronli J, Lund A. Blocking blue light during mania - markedly increased regularity of sleep and rapid improvement of symptoms: a case report. Bipolar Disord. 2014;16(8):894–8.
25.Henriksen TE, Skrede S, Fasmer OB, Schoeyen H, Leskauskaite I, Bjorke-Bertheussen J, et al. Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial. Bipolar Disord. 2016;18(3):221–32.
26.Burkhart K, Phelps JR. Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiol Int. 2009;26(8):1602–12.
27.Esaki Y, Kitajima T, Ito Y, Koike S, Nakao Y, Tsuchiya A, et al. Wearing blue light-blocking glasses in the evening advances circadian rhythms in the patients with delayed sleep phase disorder: An open-label trial. Chronobiol Int. 2016;33(8):1037–44.
28.Esaki Y, Kitajima T, Takeuchi I, Tsuboi S, Furukawa O, Moriwaki M, et al. Effect of blue-blocking glasses in major depressive disorder with sleep onset insomnia: A randomized, double-blind, placebo-controlled study. Chronobiol Int. 2017;34(6):753–61.
29.Shechter A, Kim EW, St-Onge MP, Westwood AJ. Blocking nocturnal blue light for insomnia: A randomized controlled trial. J Psychiatr Res. 2018;96:196–202.
30.Feifel D. Transforming the psychiatric inpatient unit from short-term pseudo-asylum care to state-of-the-art treatment setting. Psychiatry (Edgmont). 2008;5(9):47–50.
31.Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–7.
32.Nowozin C, Wahnschaffe A, Rodenbeck A, de Zeeuw J, Hadel S, Kozakov R, et al. Applying melanopic lux to measure biological light effects on melatonin suppression and subjective sleepiness. Curr Alzheimer Res. 2017.
33.Rahman SA, St Hilaire MA, Lockley SW. The effects of spectral tuning of evening ambient light on melatonin suppression, alertness and sleep. Physiol Behav. 2017;177:221–9.
34.Levine RJ. Deferred consent. Control Clin Trials. 1991;12(4):546–50; discussion 51–2.
35.Abramson NS, Meisel A, Safar P. Deferred consent. A new approach for resuscitation research on comatose patients. JAMA. 1986;255(18):2466–71.
36.Foex BA. The problem of informed consent in emergency medicine research. Emerg Med J. 2001;18(3):198–204.
37.Organization WH. The ICD–10 Classification of Mental and Behavioural Disorders: Diagnostic criteria for research. Geneva1993.
38.Pallesen S, Gronli J, Myhre K, Moen F, Bjorvatn B, Hanssen I, et al. A Pilot Study of Impulse Radio Ultra Wideband Radar Technology as a New Tool for Sleep Assessment. J Clin Sleep Med. 2018;14(7):1249–54.
39.Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4(7):28–37.
40.Bandelow B, Baldwin DS, Dolberg OT, Andersen HF, Stein DJ. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder? J Clin Psychiatry. 2006;67(9):1428–34.
41.Kadouri A, Corruble E, Falissard B. The improved Clinical Global Impression Scale (iCGI): development and validation in depression. BMC Psychiatry. 2007;7:7.
42.Linaker OM, Busch-Iversen H. Predictors of imminent violence in psychiatric inpatients. Acta Psychiatr Scand. 1995;92(4):250–4.
43.Woods P, Almvik R. The Broset violence checklist (BVC). Acta Psychiatr Scand Suppl. 2002(412):103–5.
44.Almvik R, Woods, P., Rasmussen, K. The Brøset Violence Checklist (BVC): Sensitivity, Specificity and inter-rater Reliability. Journal of interpersonal violence. 2000;15(12):1284–96.
45.Palmstierna T, Wistedt B. Staff observation aggression scale, SOAS: presentation and evaluation. Acta Psychiatr Scand. 1987;76(6):657–63.
46.Nijman HL, Palmstierna T, Almvik R, Stolker JJ. Fifteen years of research with the Staff Observation Aggression Scale: a review. Acta Psychiatr Scand. 2005;111(1):12–21.
47.Viola AU, James LM, Schlangen LJ, Dijk DJ. Blue-enriched white light in the workplace improves self-reported alertness, performance and sleep quality. Scand J Work Environ Health. 2008;34(4):297–306.
48.Kahan BC, Rushton H, Morris TP, Daniel RM. A comparison of methods to adjust for continuous covariates in the analysis of randomised trials. BMC Med Res Methodol. 2016;16:42.
49.Vittinghoff E. GDV, Shiboski S. C., & McCulloch C. E. Regression methods in biostatistics linear, logistic, survival, and repeated measures models. 2nd ed. New York: Springer; 2012.
50.Hill AB. Medical ethics and controlled trials. Br Med J. 1963;1(5337):1043–9.
51.Truog RD, Robinson W, Randolph A, Morris A. Is informed consent always necessary for randomized, controlled trials? N Engl J Med. 1999;340(10):804–7.